See also this year's filing and all EDGAR filings for this company.
PDF Report 0001236997_2020_Counterpath_CORP.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | No stock price available | subcommand.plot | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001236997')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001236997, Counterpath CORP
xvar | xval | |
---|---|---|
0 | LiabilitiesCurrent | 4,885,095 |
1 | LongTermDebt | 0 |
2 | remainder_Liabilities | 3,013,794 |
3 | IntangibleAssets | 6,766,085 |
4 | AssetsNoncurrent | 0 |
5 | AssetsCurrent | 4,126,387 |
6 | PropertyPlantAndEquipmentNet | 59,914 |
7 | remainder_Assets | 172,400 |
8 | SellingAndMarketingExpense | 4,061,921 |
9 | GeneralAndAdministrativeExpense | 4,098,173 |
10 | ResearchAndDevelopmentExpense | 5,547,587 |
11 | remainder_Expenses | 2,223,984 |
12 | remainder_Revenues | 10,764,904 |
13 | remainder_NetIncome | 153,322 |
14 | remainder_ComprehensiveNetIncome | -633,254 |
yvar | yval | |
---|---|---|
0 | Liabilities | 7,898,889 |
1 | Assets | 11,124,786 |
2 | Expenses | 15,931,665 |
3 | Revenues | 10,764,904 |
4 | StockholdersEquity | 3,225,897 |
5 | NetIncome | -5,013,439 |
6 | ComprehensiveNetIncome | -5,646,693 |
7 | BaseVar | 23,253,410 |
8 | EconomicCapitalRatiobeforeLimitedLiability | 0.526 |
9 | EconomicCapitalRatio | 2.63 |